Intercure Ltd. (INCR) stock
INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.63−0.16 (-4.22%)
Close on Nov 16, 2026Market cap $198.49MP/E –Yield –
Intercure EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Intercure's EV/EBITDA was 27.3× on Feb 29, 2024, against 49.2× a year earlier. Over the last 2 years it ranged from 15.0× to 119.3×, with a median of 49.2×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Feb 29, 2024 | 27.3× | +10.1 |
| 2023 | Dec 29, 2023 | 17.2× | −43.0 |
| 2022 | Dec 30, 2022 | 60.3× | – |
See a number that looks wrong?